Long-term outcomes and GVHD in patients receiving hematopoietic cell transplants abroad: A 14-year UAE multi-center cohort
Syed, N.; Abuhaleeqa, M.; Al Kaabi, F. M.; Alzein, N.; Aabideen, Z.; M. Al-Awadhi, A.; Alam, A.; Ali Khan, A.; Afrooz, I.; Mir, F. A.; Alhasan, R.; Damlaj, M.; Anaam, O. T.; Mohamed, M. H.; ElGhazali, G.; Mheidly, K.; Hashmi, S.
Show abstract
BackgroundHematopoietic cell transplant (HCT) outcomes are well characterized in clinical trials and international registries, but data remain scarce for patients who undergo transplantation abroad and return home for follow-up. While transplant centers typically report procedural details and early mortality for this cohort, long-term survival and chronic graft versus host disease (GVHD) outcomes are seldom captured, underscoring the need for comprehensive reporting. MethodsWe conducted a retrospective, multi-center study of all HCT recipients followed at all the three tertiary hospitals in Abu Dhabi, UAE, between 2009 and 2023. Patient demographics, transplant characteristics, overall survival (OS), and GVHD incidence were extracted from medical records. Kaplan-Meier OS estimates were calculated for diseases with [≥]20 cases; crude survival was reported for rarer indications. ResultsA total of 454 HCTs were analyzed: 350 (77.1%) allogeneic and 104 (22.9%) autologous. Adults undergoing allogeneic HCT were relatively young (median age 35.3 years), reflecting referral practices and the UAEs demographic profile. An unexpected female predominance was observed in pediatric malignancies and immune deficiencies. Matched unrelated donor (MUD) transplants were rare, and the trend remained low over time, underscoring reliance on matched related donor (MRD) and mismatched related donor (MMRD). The incidence of GVHD was high, approaching the upper range of international reports: 69.2% in adults and 45.7% in children. In adults with AML, acute GVHD was associated with an inferior 5-year OS (67.9% vs. 86.2%, p=0.036), whereas chronic GVHD did not significantly impact outcomes. In pediatric AML, both acute and chronic GVHD were linked to poorer survival (<50% at 5 years), while outcomes for B/T-ALL, thalassemia, and SCID exceeded 85-90% at 5 years regardless of GVHD status. ConclusionsHCT outcomes in this transplant tourism cohort were generally comparable to international benchmarks, yet notable for younger adult recipients, predominance of allogeneic over autologous procedures, limited use of MUDs, and a high incidence of GVHD. These observations highlight the urgent need to establish sustainable local transplant capacity, build donor registries, and implement aggressive GVHD prevention and treatment practices to improve outcomes in the UAE.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Exploring the role of Large Language Models (LLMs) in hematology: a systematic review of applications, benefits, and limitations 91%
- Validation of the IMPEDE VTE Score for Prediction of Venous Thromboembolism in Multiple Myeloma: A Retrospective Cohort Study 90%
- Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T cell response 88%
Similar papers in this journal
- Trends in underlying causes of death in solid organ transplant recipients between 2010 and 2020: Using the CLASS method for determining specific causes of death 93%
- Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms 92%
- Investigation of HLA susceptibility alleles and genotypes with hematological disease among Chinese Han population 90%
Similar papers in this journal
- Donor Bone Marrow Derived Macrophage Engraftment into the Central Nervous System of Allogeneic Transplant Patients 93%
- Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia 92%
- Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in Multiple Myeloma 91%
Similar papers in this journal
- Dental biofilm microbiota dysbiosis is associated with the risk of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation 93%
- Perturbations of the T-cell immune repertoire in kidney transplant rejection 92%
- Immune Composition of the Mononuclear Cell Fraction of Human Umbilical Cord Blood 92%
Similar papers in this journal
- Clinicopathologic Correlates and Natural History of Atypical Chronic Myeloid Leukemia 95%
- Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma 92%
- Inhibitory KIR-Ligand Interactions and Relapse Protection Following HLA Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myelogenous Leukemia 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.